ChlorproMAZINE Hydrochloride Tablets, USP, 10 mg, packaged in cartons of 100 TABLETS (10x10), Rx ...

FDA Recall #D-0366-2025 — Class II — April 14, 2025

Recall #D-0366-2025 Date: April 14, 2025 Classification: Class II Status: Ongoing

Product Description

ChlorproMAZINE Hydrochloride Tablets, USP, 10 mg, packaged in cartons of 100 TABLETS (10x10), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7129-61

Reason for Recall

CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit

Recalling Firm

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — La Vergne, TN

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

133 cartons

Distribution

Nationwide USA

Code Information

Lot#: N02114, Exp 12/31/2025

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated